05.12.2016 • NewsMergers & Acquisitions (M&A)foamBASF

Gurit Takes BASF’s Italian PET Assets

(c) BASF
(c) BASF

Swiss composites producer Gurit has acquired BASF’s polyethylene terephthalate (PET) structural foam business for an undisclosed sum. The transaction comprises the German group’s PET operations in Volpiano, Italy, and its intellectual property. The Swiss group said the acquisition will strengthen its portfolio of structural core materials, with the Kerdyn brand reinforcing its offering to the wind, marine, transport and construction industries.

The deal also adds sizable European PET production capacity to the Watwil-headquartered firm’s existing operations in China. In addition, Gurit stands to gains significant extrusion process technology and innovation knowhow. The “special” extrusion process, for example, enables the production of high-performance PET foams with very high densities.

BASF’s speciality PET business acquired in March 2012 from Italian firm B.C. Foam has a turnover in the “low single digit million” Swiss francs. Gurit said it intends to integrate and further develop the Italian operations as part of its Composite Materials business unit. When buying the business, BASF said the acquisition would further strengthen its position as a leading foam provider and extend its product range for the growing global wind energy market. In the meantime, it seems to have determined the business to be non-core.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.